Ana Balanzategui

2.9k total citations
70 papers, 1.5k citations indexed

About

Ana Balanzategui is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Ana Balanzategui has authored 70 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Genetics, 31 papers in Hematology and 23 papers in Pathology and Forensic Medicine. Recurrent topics in Ana Balanzategui's work include Chronic Lymphocytic Leukemia Research (29 papers), Lymphoma Diagnosis and Treatment (23 papers) and Multiple Myeloma Research and Treatments (13 papers). Ana Balanzategui is often cited by papers focused on Chronic Lymphocytic Leukemia Research (29 papers), Lymphoma Diagnosis and Treatment (23 papers) and Multiple Myeloma Research and Treatments (13 papers). Ana Balanzategui collaborates with scholars based in Spain, Portugal and Netherlands. Ana Balanzategui's co-authors include Marcos González, Jesús F. San Miguel, Ramón García‐Sánz, Carmen Chillón, Alberto Órfão, Miguel Alcoceba, María Eugenia Sarasquete, Júlia Almeida, Margarida Lima and Carlos Santamaría and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and American Journal Of Pathology.

In The Last Decade

Ana Balanzategui

68 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana Balanzategui Spain 25 539 492 491 459 440 70 1.5k
Benet Nomdedeu Spain 22 592 1.1× 829 1.7× 881 1.8× 349 0.8× 361 0.8× 88 1.8k
Surender Juneja Australia 20 541 1.0× 538 1.1× 489 1.0× 375 0.8× 288 0.7× 85 1.3k
Ángel León Spain 14 328 0.6× 253 0.5× 1.1k 2.2× 405 0.9× 687 1.6× 21 1.6k
Kamel Laribi France 17 329 0.6× 321 0.7× 604 1.2× 606 1.3× 336 0.8× 62 1.2k
David Hakimian United States 17 446 0.8× 657 1.3× 295 0.6× 274 0.6× 209 0.5× 48 1.1k
Kenton Wride United States 10 544 1.0× 838 1.7× 1.4k 2.7× 459 1.0× 626 1.4× 28 1.9k
R. Kuse Germany 26 763 1.4× 703 1.4× 1.4k 2.9× 734 1.6× 518 1.2× 78 2.4k
Rajko Kušec Croatia 24 341 0.6× 887 1.8× 1.0k 2.1× 280 0.6× 979 2.2× 104 2.0k
Lourdes Escoda Spain 20 551 1.0× 519 1.1× 977 2.0× 567 1.2× 665 1.5× 57 1.7k
M. L. Vegna Italy 14 186 0.3× 218 0.4× 765 1.6× 296 0.6× 517 1.2× 20 1.2k

Countries citing papers authored by Ana Balanzategui

Since Specialization
Citations

This map shows the geographic impact of Ana Balanzategui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Balanzategui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Balanzategui more than expected).

Fields of papers citing papers by Ana Balanzategui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Balanzategui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Balanzategui. The network helps show where Ana Balanzategui may publish in the future.

Co-authorship network of co-authors of Ana Balanzategui

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Balanzategui. A scholar is included among the top collaborators of Ana Balanzategui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Balanzategui. Ana Balanzategui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
García‐Álvarez, María, Cristina Jiménez, Alejandro Medina, et al.. (2023). Single-Cell DNA Sequencing and Immunophenotypic Profiling to Track Clonal Evolution in an Acute Myeloid Leukemia Patient. Biomedicines. 12(1). 66–66. 2 indexed citations
2.
Lima, Margarida, Neus Villamor, Susana Bárrena, et al.. (2021). Anti-TRBC1 Antibody-Based Flow Cytometric Detection of T-Cell Clonality: Standardization of Sample Preparation and Diagnostic Implementation. Cancers. 13(17). 4379–4379. 21 indexed citations
3.
Boix, Francisco, Luis Marı́n, Miguel Alcoceba, et al.. (2021). Allele and haplotype frequencies of HLA-A, -B, -C, -DRB1, -DQB1 and -DQA1 in Castile and Leon region from North West of Spain. Human Immunology. 82(8). 549–550. 2 indexed citations
4.
Corchete, Luís A., María García‐Álvarez, Cristina Jiménez, et al.. (2019). A New Next-Generation Sequencing Strategy for the Simultaneous Analysis of Mutations and Chromosomal Rearrangements at DNA Level in Acute Myeloid Leukemia Patients. Journal of Molecular Diagnostics. 22(1). 60–71. 10 indexed citations
5.
Jiménez, Cristina, María García‐Álvarez, Miguel Alcoceba, et al.. (2018). Unraveling the heterogeneity of IgM monoclonal gammopathies: a gene mutational and gene expression study. Annals of Hematology. 97(3). 475–484. 17 indexed citations
6.
Medina, Alejandro, Cristina Jiménez, María Eugenia Sarasquete, et al.. (2018). VDJH Gene Repertoire Analysis in Multiple Myeloma (MM) Patients: Correlation with Clinical Data. Blood. 132(Supplement 1). 4446–4446. 1 indexed citations
7.
Jiménez, Cristina, Sara Alonso, Miguel Alcoceba, et al.. (2017). From Waldenström’s macroglobulinemia to aggressive diffuse large B-cell lymphoma: a whole-exome analysis of abnormalities leading to transformation. Blood Cancer Journal. 7(8). e591–e591. 30 indexed citations
8.
Bueno, Clara, José Luis Sardina, Bruno Di Stefano, et al.. (2015). Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα. Leukemia. 30(3). 674–682. 33 indexed citations
9.
Sebastián, Elena, Miguel Alcoceba, Ana Balanzategui, et al.. (2012). Molecular Characterization of Immunoglobulin Gene Rearrangements in Diffuse Large B-Cell Lymphoma. American Journal Of Pathology. 181(5). 1879–1888. 29 indexed citations
10.
Bárrena, Susana, Antonio López‐Serrano, Ana Rasillo, et al.. (2011). Flow cytometry immunophenotyping of fine-needle aspiration specimens: utility in the diagnosis and classification of non-Hodgkin lymphomas. Histopathology. 58(6). 906–918. 46 indexed citations
12.
Sarasquete, María Eugenia, Ramón García‐Sánz, Luis Marı́n, et al.. (2008). Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: a genome-wide single nucleotide polymorphism analysis. Blood. 112(7). 2709–2712. 164 indexed citations
13.
González‐Porras, José Ramón, Francisco Martín‐Herrero, Ramón García‐Sánz, et al.. (2006). Hyperhomocysteinemia is a risk factor of recurrent coronary event in young patients irrespective to the MTHFR C677T polymorphism. Thrombosis Research. 119(6). 691–698. 4 indexed citations
14.
Sandberg, Yorick, Júlia Almeida, Marcos González, et al.. (2006). TCRγδ+ large granular lymphocyte leukemias reflect the spectrum of normal antigen-selected TCRγδ+ T-cells. Leukemia. 20(3). 505–513. 62 indexed citations
15.
González‐Porras, José Ramón, Ramón García‐Sánz, Ignacio Alberca, et al.. (2005). Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation. Blood Coagulation & Fibrinolysis. 17(1). 23–28. 27 indexed citations
16.
Chillón, Carmen, Ramón García‐Sánz, Ana Balanzategui, et al.. (2004). FLT3-activating mutations are associated with poor prognostic features in AML at diagnosis but they are not an independent prognostic factor. The Hematology Journal. 5(3). 239–246. 25 indexed citations
17.
González, David, Ana Balanzategui, Ramón García‐Sánz, et al.. (2003). Incomplete DJH rearrangements of the IgH gene are frequent in multiple myeloma patients: immunobiological characteristics and clinical implications. Leukemia. 17(7). 1398–1403. 28 indexed citations
18.
González, David, Marcos González, M. Eva Alonso, et al.. (2003). Incomplete DJH rearrangements as a novel tumor target for minimal residual disease quantitation in multiple myeloma using real-time PCR. Leukemia. 17(6). 1051–1057. 22 indexed citations
19.
Lima, Margarida, Lucas Miranda Marques, Carmen Martín, et al.. (2001). Association of CD4 + /CD56 + /CD57 + /CD8 +dim large granular lymphocytic leukemia, splenic B-cell lymphoma with circulating villous lymphocytes, and idiopathic erythrocytosis. Annals of Hematology. 80(11). 685–690. 14 indexed citations
20.
Mateos, María‐Victoria, Marcos González, Ana Balanzategui, et al.. (2000). Status of methylation of p16 gene in multiple myeloma: a comparative study of three methods for its detection. Clinical Biochemistry. 33(5). 415–418. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026